Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial - Concepedia

Concepedia

Publication | Open Access

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial

DOI Full Paper Access

21

Citations

19

References

2023

Year

Evandro de Azambuja, Elisa Agostinetto, Marion Procter, Daniel Eiger, Noam Pondé, Sébastien Guillaume, Damien Parlier, Matteo Lambertini, A. Desmet, Carmela Caballero,

Breast OncologyOncologyDual Anti-her2 BlockadePharmacologyCardiac SafetyAphinity TrialBreast CancerPharmacotherapyCancer TreatmentMedicine

References

	Year	Citations

Page 1

Page 1